Remdesivir-bisPropionate: An Improved SARS-CoV-2 Derivative PK/PD Study
Remdesivir-bisPropionate is emerging as a clinically enhanced derivative of remdesivir, designed to combat SARS-CoV-2 with improved pharmacological properties. Recent scientific literature published in PLOS ONE details the comparative pharmacokinetics and ... Read More